search

Active clinical trials for "Schizophrenia"

Results 2321-2330 of 3086

Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail...

Tobacco Use DisorderSchizophrenia

In the present study, we investigate healthy subjects and schizophrenic patients who frequently show very low attentional capacity with functional magnetic resonance imaging (fMRI) and electrophysiology (EEG) during attention-requiring tasks to assess the level of attentional network activity.

Completed22 enrollment criteria

Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families

SchizophreniaBipolar Disorder1 more

Representative payees, mostly family members, manage Social Security Administration funds of more than one million people with psychiatric disabilities. Although studies show payeeship can be used coercively, foster dependency, reduce work incentives, lead to family conflict and even violence, there has been little systematic research on how to lower these significant barriers to community integration. The investigators' long term goal is to promote recovery among adults with psychiatric disabilities who have payees by reducing downsides associated with what has been called "the nation's largest guardianship system." The investigators' objective in the current application is to evaluate a pilot-tested, stakeholder-informed intervention that is grounded in principles of psychiatric rehabilitation and encourages consumers with psychiatric disabilities and their family members to collaborate within the representative payee arrangement.

Completed8 enrollment criteria

Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Original Study...

Schizophrenia

This trial is designed to determine if administering repetitive transcranial magnetic stimulation (rTMS) simultaneously to two sites in the temporal lobes, one on the left and one on the right, produces greater improvements in "voices" and other symptoms of schizophrenia compared to rTMS given to just one site in the temporal lobes.

Completed5 enrollment criteria

A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition...

Schizophrenia

This study will develop and evaluate the effectiveness of a self-management program for adults living with both schizophrenia and a co-occurring medical condition.

Completed17 enrollment criteria

Antipsychotic Polypharmacy: Prevalence, Background and Consequences

Schizophrenia

The primary purpose of the study is to investigate whether an intensive educational intervention can reduce the use of antipsychotic polypharmacy. It is hypothesised that the use of antipsychotic polypharmacy is, in some degree, dependent on non-patient related factors.

Completed3 enrollment criteria

The Psychiatric Rehabilitation Approach to Weight Loss

Schizophrenic Disorders

The primary aim of the project is to examine the efficacy of the Psychiatric Rehabilitation Weight Loss program in reduction of weight and body mass index (BMI.

Completed14 enrollment criteria

Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers

Schizophrenia

This study will determine whether using a pager improves medication adherence in people with schizophrenia.

Completed8 enrollment criteria

Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia

SmokingNicotine Dependence4 more

Cigarette smoking decreases life expectancy, causes devastating health complications, and costs society billions of dollars each year. These untoward consequences are especially pronounced among persons with schizophrenia (SCZ) because approximately 80% to 95% of this group smokes cigarettes. These high prevalence rates underscore the need for research investigating the determinants of smoking in patients with SCZ. Several researchers have observed that nicotine improves specific symptoms of SCZ including negative symptoms, negative affect, and cognitive deficits. This has led to the hypothesis that patients with SCZ smoke in an attempt to self-medicate. However, the mechanism(s) by which nicotine has its positive effect on symptoms remains unclear. The current proposal posits that neural inhibition (NI) is a physiological mechanism of this effect, while variation in the alpha-7-nicotinic receptor subunit gene (CHRNA7) represents the genetic underpinnings of these processes. The proposed study will assess NI and symptom improvement after acute administration of nicotine to both smokers and nonsmokers with SCZ. In addition, NI and CHRNA7 variation will be tested as predictors of patients' ability to reduce/quit smoking following smoking treatment. These data may lead to the development of new pharmacological strategies for treating the symptoms of SCZ and new methods for assisting these patients to quit smoking.

Completed9 enrollment criteria

A PET Study With RO5545965 in Healthy Male Volunteers

Schizophrenia

This single center, open-label study will evaluate the PK-PDE10A Enzyme Occupancy Relationship of RO5545965 after a single dose in healthy male volunteers by positron emission tomography (PET).

Completed15 enrollment criteria

A Study to Assess Learning Performance in Patients With Schizophrenia and Young and Elderly Healthy...

Schizophrenia

The purpose of this study is to measure and contrast implicit and explicit learning performance in patients with schizophrenia relative to young and elderly healthy volunteers.

Completed14 enrollment criteria
1...232233234...309

Need Help? Contact our team!


We'll reach out to this number within 24 hrs